OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Precision Medicine in NSCLC: Ramifications of Recent Data

home / peer-exchange / nsclc-precision-medicine-recent-data
Molecular Testing for NSCLC in 2019

EP. 1: Molecular Testing for NSCLC in 2019

July 19th 2019
Acting on Molecular Testing Results in NSCLC

EP. 2: Acting on Molecular Testing Results in NSCLC

July 19th 2019
Molecular Testing for Patients With Symptomatic NSCLC

EP. 3: Molecular Testing for Patients With Symptomatic NSCLC

July 19th 2019
How Are We Using Liquid Biopsy in NSCLC?

EP. 4: How Are We Using Liquid Biopsy in NSCLC?

July 19th 2019
EGFR-Mutated NSCLC; Where We Are Now?

EP. 5: EGFR-Mutated NSCLC; Where We Are Now?

July 19th 2019
Treating EGFR+ NSCLC Brain Metastases

EP. 6: Treating EGFR+ NSCLC Brain Metastases

July 19th 2019
Novel EGFR Inhibitor Combinations for NSCLC

EP. 7: Novel EGFR Inhibitor Combinations for NSCLC

July 19th 2019
RELAY: Erlotinib with Ramucirumab for EGFR+ NSCLC

EP. 8: RELAY: Erlotinib with Ramucirumab for EGFR+ NSCLC

July 19th 2019
Novel EGFR Exon 20 Directed Therapies for NSCLC

EP. 9: Novel EGFR Exon 20 Directed Therapies for NSCLC

July 19th 2019
ALK-Rearranged Lung Cancer

EP. 10: ALK-Rearranged Lung Cancer

July 19th 2019
Managing CNS Disease in ALK-Rearranged NSCLC

EP. 11: Managing CNS Disease in ALK-Rearranged NSCLC

July 19th 2019
ROS1-Rearranged NSCLC

EP. 12: ROS1-Rearranged NSCLC

July 19th 2019
Treatment of NSCLC Rare Genotypes

EP. 13: Treatment of NSCLC Rare Genotypes

July 19th 2019
The NTRK Family of Fusions in NSCLC

EP. 14: The NTRK Family of Fusions in NSCLC

July 19th 2019
Treatment of NSCLC With RET Fusions

EP. 15: Treatment of NSCLC With RET Fusions

July 19th 2019

Latest Conference Coverage

T-DM1 Plus Palbociclib Displays Activity in HER2+ Metastatic Breast Cancer

EL1SSAR Data Shed Light on Leveraging Atezolizumab Plus Nab-Paclitaxel in PD-L1+ TNBC

Pretreatment ctDNA Status Is Associated With Distant Recurrent-Free Survival in Early Breast Cancer

Zanidatamab/Chemotherapy Yields Responses and Is Safe in HER2-Expressing Metastatic Breast Cancer

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact